Provides support towards mission of Ohio State's Drug Development
Institute (DDI) under OSUCCC-The James to accelerate drug discovery and development to speed new cancer treatments to patients. DDI offers unique, proven approach to identify and optimize value of promising
compounds created by Ohio State cancer research experts and to leverage alliances with partners within OSU and the pharmaceutical and biotech
industry. Funds are allocated by DDI's director in consultation with
CEO/director of The James/CCC.
If you have a Donor ID, please enter here.
If you went to Ohio State, when was the last year you attended?